Showing results (1581-1590 of 1,957) with videos related to
Sort By:
Pageof 196
American Heart Journal|November 11, 2019
Same-day discharge among patients undergoing elective PCI: Insights from the VA CART ProgramJennifer A Rymer, Colin I O'Donnell, Mary E Plomondon, et al.BMC Nephrology|August 14, 2025
UK Kidney Association Clinical Practice Guideline on vascular access for haemodialysisEmma Aitken, Hameed Anijeet, Damien Ashby, et al.Hepatology Communications|June 17, 2022
Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signatureMyung-Ho Kim, Mi-Young Kim, Shadi Salloum, et al.Pediatric Nephrology (Berlin, Germany)|March 13, 2025
Predictors of hyperkalemia in pediatric patients on dialysis: international prospective observational studyFabio Paglialonga, Rukshana Shroff, Ilona Zagozdzon, et al.Cancer Medicine|June 11, 2020
Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinomaJane E Rogers, Jonathan D Mizrahi, Lianchun Xiao, et al.BMC Ophthalmology|May 17, 2017
Atypical retinal pigment epithelial defects with retained photoreceptor layers: a so far disregarded finding in age related macular degenerationHelena Giannakaki-Zimmermann, Giuseppe Querques, Inger Christine Munch, et al.The Oncologist|May 11, 2017
Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective StudyTalia Golan, Maria Raitses-Gurevich, Robin K Kelley, et al.Human Pathology|February 11, 2014
Molecular characterization of gallbladder cancer using somatic mutation profilingMilind Javle, Asif Rashid, Chaitanya Churi, et al.ESMO Gastrointestinal Oncology|February 6, 2026
Quantitative benefit-risk assessment of data from the phase III ClarIDHy study of ivosidenib versus placebo in patients with mIDH1 cholangiocarcinomaJ W Valle, G K Abou-Alfa, R K Kelley, et al.Kidney International|February 5, 2015
Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conferenceMarkus Ketteler, Grahame J Elder, Pieter Evenepoel, et al.Pageof 196